Vascular cognitive impairment and dementia: Mechanisms, treatment, and future directions

VCT Mok, Y Cai, HS Markus - International Journal of Stroke, 2024 - journals.sagepub.com
Worldwide, around 50 million people live with dementia, and this number is projected to
triple by 2050. It has been estimated that 20% of all dementia cases have a predominant …

Current and future treatments of vascular cognitive impairment

BYM Ip, H Ko, BYK Lam, LWC Au, AYL Lau, J Huang… - Stroke, 2024 - Am Heart Assoc
Vascular cognitive impairment (VCI) traditionally encompasses a variety of cerebrovascular
pathologies that contribute to varying levels of cognitive impairment, ranging from subtle to …

[HTML][HTML] Direct oral anticoagulants are associated with lower risk of dementia in patients with atrial fibrillation

D Sagris, G Ntaios, BJR Buckley, SL Harrison… - European Journal of …, 2024 - Elsevier
Background and aim Atrial fibrillation (AF) is associated with increased risk of dementia.
Whether direct oral anticoagulation (DOAC) reduce this risk compared to vitamin-K …

Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk

AR Mobley, A Subramanian, A Champsi, X Wang… - Nature Medicine, 2024 - nature.com
The prevention of thromboembolism in atrial fibrillation (AF) is typically restricted to patients
with specific risk factors and ignores outcomes such as vascular dementia. This population …

[HTML][HTML] Association between dementia and left atrial appendage occlusion in patients with atrial fibrillation: A TriNetX-based retrospective cohort study with target trial …

KH Lu, CY Hsieh, D Hsiang-Te Tsai, ECC Lai… - Heart Rhythm O2, 2024 - Elsevier
Background Atrial fibrillation (AF) is a common cardiac arrhythmia linked to an elevated risk
of stroke and dementia. Emerging observational evidence suggests that left atrial …

Dementia risk reduction between DOACs and VKAs in AF: A systematic review and meta‐analysis

A Chokesuwattanaskul, N Prasitlumkum… - Journal of …, 2024 - Wiley Online Library
Abstract Introduction Direct oral anticoagulants (DOACs) become the recommended
treatment over vitamin K antagonists (VKA) in patients with non‐valvular atrial fibrillation …

[HTML][HTML] Unraveling the thrombin–Alzheimer's connection: Oral anticoagulants as potential neuroprotective therapeutics

K Grossmann - Advanced Neurology, 2024 - accscience.com
In Alzheimer's disease (AD), toxic amyloids formed by amyloid-β (Aβ) proteins and tau are
implicated in the development of inflammatory, vascular, and neurodegenerative brain …

[HTML][HTML] Reducing the Risk of Dementia in Atrial Fibrillation

S Kumar, C Narasimhan - JACC: Asia, 2023 - jacc.org
Atrial fibrillation (AF) is the most common sustained dysrhythmia encountered in clinical
practice. 1 A meta-analysis that included patients from 8 Asian countries showed an AF …

[HTML][HTML] Антикоагулянтная терапия у пожилых пациентов с фибрилляцией предсердий в сложных клинических ситуациях: позиции апиксабана

НМ Воробьева, ОН Ткачева - Атмосфера. Новости кардиологии, 2024 - cyberleninka.ru
Пожилые пациенты с фибрилляцией предсердий (ФП) требуют особого внимания
врача. При выборе антикоагулянта необходимо учитывать риски не только инсульта …

Атмосфера. Новости кардиологии 2024/N 2

НМ Воробьева, ОН Ткачева - atmosphere-ph.ru
Atmosphere-ph.ru Welcome to Издательство Атмосфера · Журналы · Книги · О проекте ·Электронные
версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” …